_    ___ ___      _                               
   / \  |_ _/ _ \ ___| |_ _ __ ___  __ _ _ __ ___  ___
  / _ \  | | | | / __| __| '__/ _ \/ _` | '_ ` _ \/ __|
 / ___ \ | | |_| \__ \ |_| | |  __/ (_| | | | | | \__ \
/_/   \_\___\___/|___/\__|_|  \___|\__,_|_| |_| |_|___/

Invidious > Channel > EBD Group

EBD Group	1100 subscribers    RSS
View channel on YouTube Videos Playlists

YT 1 hour 8 minutes 53 seconds EBD Group BIO-Europe® 2016- Value and the pricing of innovation YT 1 hour 33 minutes 13 seconds EBD Group BIO-Europe® 2016: Big pharma's approach to digital medicine YT 1 hour 4 minutes 18 seconds EBD Group BIO-Europe® 2016: Immunotherapies: Partnership models driving cures

YT 1 hour 2 minutes 31 seconds EBD Group BIO-Europe® 2016: The new frontier: Aging and health YT 10 minutes 43 seconds EBD Group BIO-Europe® 2016: Neovacs CEO outlines clinical timeline for lupus drug YT 12 minutes 45 seconds EBD Group BIO-Europe® 2016: AiCuris seeks partners for antibacterial programs

YT 11 minutes 36 seconds EBD Group BIO-Europe® 2016: eTheRNA CEO outlines development plan in cancer RNA space YT 7 minutes 8 seconds EBD Group BIO-Europe® 2016: Cinfa outlines biosimilar development areas and deal opportunities YT 3 minutes 59 seconds EBD Group BIO-Europe® 2016: Freshly-appointed Auspherix CEO highlights new antibiotic class

YT 6 minutes 35 seconds EBD Group BIO-Europe® 2016: Karus CEO highlights niche indications for oncology innovation YT 10 minutes 27 seconds EBD Group BIO-Europe® 2016: BioNTech's Sean Marett explains Genentech deal rationale YT 8 minutes 40 seconds EBD Group BIO-Europe® 2016: Denali deal and F-star’s innovative asset centric business model

YT 4 minutes 39 seconds EBD Group BIO-Europe® 2016: J&J's Richard Mason: 'Biomedical Innovation Can Come From Anywhere' YT 8 minutes 19 seconds EBD Group BIO-Europe® 2016: Peter Fong on Genentech's science shopping list, recent BioNtech deal YT 8 minutes 32 seconds EBD Group BIO-Europe® 2016: Dimerix CEO explains company's different drug combo R&D strategy

YT 10 minutes 24 seconds EBD Group BIO-Europe® 2016: How are regulatory changes affecting early stage R&D in China? YT 7 minutes 3 seconds EBD Group BIO-Europe® 2016: Vaximm seeks pharma partners for T-cell/checkpoint inhibitor combos YT 7 minutes 56 seconds EBD Group BIO-Europe® 2016: Atlantic Healthcare outlines filing plans

YT 3 minutes 51 seconds EBD Group BIO-Europe® 2016: Inositec CEO on 2017 financing plans YT 8 minutes 52 seconds EBD Group BIO-Europe® 2016: Deciphera CEO on tackling cancer drug resistance YT 5 minutes 2 seconds EBD Group BIO-Europe® 2016: Promethera extends series C on interest from Asian investors

YT 3 minutes 42 seconds EBD Group BIO-Europe® 2016: AdAlta CEO on shark antibody technology YT 8 minutes 46 seconds EBD Group BIO-Europe® 2016: Opportunities For unpartnered assets YT 5 minutes 11 seconds EBD Group BIO-Europe® 2016: InflaRX CEO highlights pipeline goals